Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (151-160 of 484) with videos related to

Pageof 49
Sort By:
American Journal of Epidemiology|November 6, 2007
Integrating the predictiveness of a marker with its performance as a classifierMargaret S Pepe, Ziding Feng, Ying Huang, et al.
Urology|September 24, 2013
Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom scoreDonna P Ankerst, Cathee Till, Andreas Boeck, et al.
Journal of the National Cancer Institute|October 11, 2007
Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidenceRuth D Etzioni, Donna P Ankerst, Noel S Weiss, et al.
Medical Care|December 28, 2012
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer ScreeningRuth Etzioni, Roman Gulati, Matt R Cooperberg, et al.
American Journal of Ophthalmology|June 6, 2003
Spontaneous regression of choroidal metastasis from renal cell carcinomaAmjad M Hammad, Gianmarco R Paris, Wichard A J van Heuven, et al.
Cancer|July 15, 2009
Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention TrialZhihong Gong, Alan R Kristal, Jeannette M Schenk, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 13, 2018
Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by FinasterideJames Y Dai, Michael LeBlanc, Phyllis J Goodman, et al.
The Journal of Urology|September 23, 2014
Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculatorSonja Grill, Mahdi Fallah, Robin J Leach, et al.
The Journal of Urology|August 5, 2015
No Detrimental Effect of a Positive Family History on Long-Term Outcomes Following Radical ProstatectomyJohannes M S Brath, Sonja Grill, Donna P Ankerst, et al.
The Journal of Urology|March 17, 2009
Yearly prostate specific antigen and digital rectal examination fluctuations in a screened populationDonna Pauler Ankerst, Ryan Miyamoto, Prakash Vijay Nair, et al.
Pageof 49

Showing results (151-160 of 484) with videos related to

Sort By:
Pageof 49
American Journal of Epidemiology|November 6, 2007
Integrating the predictiveness of a marker with its performance as a classifierMargaret S Pepe, Ziding Feng, Ying Huang, et al.
Urology|September 24, 2013
Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom scoreDonna P Ankerst, Cathee Till, Andreas Boeck, et al.
Journal of the National Cancer Institute|October 11, 2007
Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidenceRuth D Etzioni, Donna P Ankerst, Noel S Weiss, et al.
Medical Care|December 28, 2012
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer ScreeningRuth Etzioni, Roman Gulati, Matt R Cooperberg, et al.
American Journal of Ophthalmology|June 6, 2003
Spontaneous regression of choroidal metastasis from renal cell carcinomaAmjad M Hammad, Gianmarco R Paris, Wichard A J van Heuven, et al.
Cancer|July 15, 2009
Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention TrialZhihong Gong, Alan R Kristal, Jeannette M Schenk, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 13, 2018
Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by FinasterideJames Y Dai, Michael LeBlanc, Phyllis J Goodman, et al.
The Journal of Urology|September 23, 2014
Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculatorSonja Grill, Mahdi Fallah, Robin J Leach, et al.
The Journal of Urology|August 5, 2015
No Detrimental Effect of a Positive Family History on Long-Term Outcomes Following Radical ProstatectomyJohannes M S Brath, Sonja Grill, Donna P Ankerst, et al.
The Journal of Urology|March 17, 2009
Yearly prostate specific antigen and digital rectal examination fluctuations in a screened populationDonna Pauler Ankerst, Ryan Miyamoto, Prakash Vijay Nair, et al.
Pageof 49